Product Information

ERYTHROMYCIN DR 250 MG TABLET is a generic product labeled by Amneal Pharmaceuticals NY LLC, priced at $2.0349 per EA under NDC 69238147103. Its NADAC has been published 244 times since Mar 23, 2022.

FDA first approved this application on Jul 2, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

ERYTHROMYCIN DR 250 MG TABLET

Erythromycin
$2.0349per EA

Strength

250 mg/1

NDC

69238147103

Classification

Generic

Dosage Form

TABLET, DELAYED RELEASE

Route

ORAL

Effective Date

11/18/2026

Active Ingredients

ERYTHROMYCIN

Approval Type

Generic (ANDA)

FDA Application

ANDA210954

FDA Approved

7/2/2019

TE Code

AB

On Market Since

7/7/2019

Pharmacological Classes

Decreased Sebaceous Gland Activity
Macrolide Antimicrobial
Macrolide
Macrolides

Price Statistics

The NADAC for ERYTHROMYCIN DR 250 MG TABLET has been published 244 times since Mar 23, 2022, and over the history we have for it it has declined 52.4%. The table below summarizes its recorded NADAC range and movement.

Current price$2.0349 per EA
All-time high$4.6777 (Jul 12, 2023)
All-time low$1.6915 (Feb 18, 2026)
52-week high$2.4837
52-week low$1.6915
Median price$2.9507
Average price$3.1178
Largest weekly change+41.1% (Mar 22, 2023)
Weeks tracked244
Tracking sinceMar 23, 2022

Price History

1W

+8.3%

1M

+5.7%

3M

-2.4%

6M

-15.2%

1Y

-4.5%

3Y

-51.4%

5Y

N/A

All

-52.4%

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 9% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of ERYTHROMYCIN DR 250 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for ERYTHROMYCIN DR 250 MG TABLET, manufactured by Amneal Pharmaceuticals NY LLC, is $2.0349 per EA (NDC 69238147103), effective Nov 18, 2026.

How has the price of ERYTHROMYCIN DR 250 MG TABLET changed over time?

Over the history we have for it, the NADAC for ERYTHROMYCIN DR 250 MG TABLET has declined 52.4%. It has been tracked across 244 weekly CMS publications since Mar 23, 2022.

What are the highest and lowest recorded NADAC prices for ERYTHROMYCIN DR 250 MG TABLET?

Since Mar 23, 2022, the NADAC for ERYTHROMYCIN DR 250 MG TABLET has ranged from a low of $1.6915 (Feb 18, 2026) to a high of $4.6777 (Jul 12, 2023), with a median of $2.9507 per EA.

Are there cheaper alternatives to ERYTHROMYCIN DR 250 MG TABLET?

Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ERYTHROMYCIN 250 MG TABLET, is $1.8452 per EA — about 9% below ERYTHROMYCIN DR 250 MG TABLET.

Who manufactures ERYTHROMYCIN DR 250 MG TABLET?

ERYTHROMYCIN DR 250 MG TABLET (NDC 69238147103) is labeled by Amneal Pharmaceuticals NY LLC, and CMS classifies it as a generic product.